News
The Analyst Landscape: 6 Takes On Boston Props
14 Jun 24
Analyst Ratings
Truist Securities Maintains Hold on Boston Props, Lowers Price Target to $67
14 Jun 24
News, Price Target, Analyst Ratings
(BXP) - Analyzing Boston Props's Short Interest
27 May 24
Short Sellers, Short Ideas, Trading Ideas
The Latest Analyst Ratings For Boston Props
24 May 24
Analyst Ratings
Barclays Maintains Equal-Weight on Boston Props, Lowers Price Target to $65
24 May 24
News, Price Target, Analyst Ratings
Evercore ISI Group Maintains Outperform on Boston Props, Lowers Price Target to $69
6 May 24
News, Price Target, Analyst Ratings
(BXP) - Analyzing Boston Props's Short Interest
3 May 24
Short Sellers, Short Ideas, Trading Ideas
Decoding 5 Analyst Evaluations For Boston Props
2 May 24
Analyst Ratings
Wedbush Maintains Neutral on Boston Props, Lowers Price Target to $63
2 May 24
News, Price Target, Analyst Ratings
Boston Props Q1 2024 FFO $1.73, Inline, Sales $839.439M Beat $808.618M Estimate
30 Apr 24
Earnings, Earnings Beats, News
BMO Capital Maintains Outperform on Boston Props, Lowers Price Target to $78
8 Apr 24
News, Price Target, Analyst Ratings
In-Depth Examination Of 7 Analyst Recommendations For Boston Props
27 Mar 24
Analyst Ratings
Barclays Maintains Equal-Weight on Boston Props, Lowers Price Target to $66
27 Mar 24
News, Price Target, Analyst Ratings
BXP Completed Sale of 45% Interest in Cambridge Life Sciences Development to Norges Bank Investment Management
25 Mar 24
News, Asset Sales
Looking Into Boston Props's Recent Short Interest
21 Mar 24
Short Sellers, Short Ideas, Trading Ideas
Press releases
BXP Declares Regular Quarterly Dividend
12 Jun 24
Press Releases
BXP to Present at Nareit's 2024 REITweek Investor Conference
28 May 24
Press Releases
BXP to Host 3rd Annual Sustainability & Impact Investor Update Webcast
6 May 24
Press Releases
BXP Announces First Quarter 2024 Results
30 Apr 24
Press Releases
BXP Releases 2023 Sustainability & Impact Report
22 Apr 24
Press Releases
BXP to Release First Quarter 2024 Financial Results on April 30, 2024
2 Apr 24
Press Releases
BXP Completes Sale of 45% Interest in Kendall Square Life Sciences Property
25 Mar 24
Press Releases